Keyphrases
Secondary Cancer
100%
Growth Hormone Treatment
100%
Tumor Recurrence
100%
Pituitary Tumor
100%
Secondary Stroke
100%
Hypopituitarism
100%
Confidence Interval
80%
Relative Risk
80%
Tumor Progression
60%
Secondary Malignancy
60%
Cerebrovascular Accident
40%
High Risk
20%
Non-associated
20%
Adult Patients
20%
Safety Profile
20%
Malignancy
20%
Meta-analysis
20%
Extracted Data
20%
Growth Hormone
20%
Risk of Bias
20%
Systematic Meta-analysis
20%
Cochrane Central Register of Controlled Trials
20%
Embase
20%
Analysis Support
20%
Stroke Risk
20%
Random-effects Meta-analysis
20%
Therapeutic Use
20%
Scopus
20%
Long-term Adverse Effects
20%
Comprehensive Search
20%
Overall Safety
20%
Cochrane Database of Systematic Reviews
20%
Medicine and Dentistry
Metastatic Carcinoma
100%
Apoplexy
100%
Tumor Recurrence
100%
Pituitary Tumour
100%
Growth Hormone
100%
Hypopituitarism
100%
Cancer
80%
Tumor Progression
60%
Hormone Replacement Therapy
60%
Meta-Analysis
40%
Systematic Review
40%
Adverse Event
20%
Retrospective Study
20%
Therapeutic Use
20%
Pharmacology, Toxicology and Pharmaceutical Science
Metastasis
100%
Tumor Recurrence
100%
Hypophysis Tumor
100%
Growth Hormone
100%
Cerebrovascular Accident
100%
Hypopituitarism
100%
Tumor Growth
60%
Replacement Therapy
60%
Adverse Event
20%
Retrospective Study
20%
Therapeutic Use
20%